Mike Cruz
Analyst · Credit Suisse. Please go ahead
So thank you Jim and good morning. I will review the results for the quarter, our capital structure and 2018 outlook. Beginning with our first quarter results on Slide 5. Our first quarter represents a solid start to the year. This financial performance demonstrates not only the underlying strength in our key end markets, but also the benefits of a diversified product portfolio. Results were driven by sales growth in both segments, which produced 7% adjusted EBITDA growth and an adjusted EBITDA margin of approximately 27%. For discussion by business segment performance, please turn to Slide 6 for our environmental catalyst and services segment or EC&S. Sales increased more than 5% to $117 million largely driven by higher pricing from the pass-through of increased sulfur cost. This helped to more than offset lower volumes from January freeze on the Gulf Coast that reduced utilization at some of our refining services customers. Sales in the Zeolyst joint venture increased 17% to $38 million, primarily from continued strong demand for emission control catalysts. Adjusted EBITDA rose 4% to $58 million, benefiting from stronger earnings from the Zeolyst joint venture that offset the timing of plant maintenance cost and lower weather-related volumes in refining services. Segment adjusted EBITDA margins of approximately 38% were lower than prior year, largely due to the impact of cost pass-throughs. As a reminder, the refining services product group is largely covered by long-term contracts, of which nearly 90% have cost pass-through provision. Under these contracts as sulfur cost rise, so do sales dollars which means that adjusted EBITDA is relatively flat with the margin percentage declines. Turning to the performance materials and chemicals segment or PM&C on Slide 7. PM&C sales were up 12% to approximately $250 million, primarily driven by contribution from the Silvatech acquisition and favorable currency. Performance materials grew by 17%, due primarily to Silvatech, offsetting a slow start to the highway striping season, given the extended winter conditions. Performance chemicals grew nearly 11% on higher sodium silicate demand for consumer products as well as favorable currency. Adjusted EBITDA increased 9% to $57 million. This was largely driven by favorable currency and higher sodium silicate sales, coupled with the absence of startup costs associated with ThermoDrop that occurred in the prior year. Adjusted EBITDA margin was 23%, slightly lower than the previous year, primarily due to product mix and higher weather-related production costs. Next I'll discuss our capital structure on Slide 8. As Jim touched on earlier, we successfully completed the refinancing of our term loan in early February. This effectively achieved three goals from improving our capital structure. With $14 million of additional annualized cash savings that helped to reduce our overall borrowing cost to approximately 5%. We extended maturities, and we maintained our prepayment flexibility. With this latest refinancing, we've reduced cash interest by $19 million in total from pre-IPO levels. Further, we've interest rate gaps in place through mid-2020, covering $1 billion of our variable interest rate debt. As a result of 1% increase in LIBOR rates will only increase our cash interest by $2 million for the rest of this year. We operate from a position of financial strength. As you can see on Slide 14 of the appendix that Jim referenced earlier, we've demonstrated a track record of consistent adjusted EBITDA growth through economic cycles. Our low cost and flexible capital structure is complemented by product and geographic diversification, cost pass-through provisions and a high-value specialty portfolio that provides the base of stability and also growth opportunities. Our confidence in our free cash flow outlook and our commitment to continue to reduce leverage by a half a turn a year are the basis for our plan to pay down at least $50 million of debt in the second half of 2018. I'm pleased to recall that the first and second quarters are seasonally the lowest for cash flow generation, while Q3 and Q4 are the strongest. Finally, on Slide 9, I'll review our full year outlook. With solid performance in the first quarter, we are maintaining our financial guidance as discussed on our year-end earnings call. Fundamentally, as we saw in 2017 and Q1, we expect continued healthy growth trends in our end markets. With our key customer positions, we're projecting top line growth of 5% to 7% in 2018, excluding the Zeolyst joint venture sales. More specifically on the segment mix, we anticipate that EC&S will grow in the mid single-digit range, while PM&C will grow in the high single-digit range. Our forecast of 4% to 8% growth in adjusted EBITDA incorporates our share of the Zeolyst joint ventures of EBITDA. While some of the mix and pass-through margin trends are expected to continue in the second quarter, we see improvement in the second half of the year based on product mix, leading to full year margins largely in line with 2017. Capital expenditures are expected to be $150 million to $155 million, and include approximately $40 million for growth capital. On D&A, please note that we have provided the Zeolyst joint venture D&A component separately, as that is also added back to calculate adjusted EBITDA, but is excluded from adjusted net income. Finally, our effective tax rate is still anticipated to be in the mid-20% range. I would note the impact of U.S. tax reform is complex. We will provide an update, if and when the adjustments to our provisional estimate recorded at the end of last year, are required. This also excludes the impact of the global intangible low tax income tax, or GILTI, implemented under U.S. tax reform, since it does not impact our cash taxes. Free cash flow is anticipated to range between $120 million and $140 million, significantly up from last year by approximately $145 million to $165 million. As seen in the bullets on this slide, this is largely driven by $50 million of lower refinancing costs, $55 million of lower interest cost, lower anticipated working capital usage of $20 million, with the balance from higher adjusted EBITDA. So to summarize, the first quarter was a good start on our 2018 goals. Results this year will demonstrate PQ's strong and sustainable free cash flow profile and we're focused on debt repayment beginning in the second half of the year, with a targeted debt reduction of at least $50 million. With that, I’ll turn the call back to Jim.